Literature DB >> 15944867

Sibutramine and the sympathetic nervous system in obese humans.

William G Haynes, Zoltan Egri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15944867     DOI： 10.1007/s10286-005-0287-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  33 in total

Review 1.  Pharmacotherapy of obesity: lessons from clinical trials in hypertension.

Authors:  William G Haynes; Allyn L Mark
Journal:  J Hypertens       Date:  2002-09       Impact factor: 4.844

2.  A clinical trial of the use of sibutramine for the treatment of patients suffering essential obesity.

Authors:  G Fanghänel; L Cortinas; L Sánchez-Reyes; A Berber
Journal:  Int J Obes Relat Metab Disord       Date:  2000-02

3.  Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors:  D Hansen; A Astrup; S Toubro; N Finer; P Kopelman; J Hilsted; S Rössner; W Saris; L Van Gaal; W James; M Goulder
Journal:  Int J Obes Relat Metab Disord       Date:  2001-04

4.  Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.

Authors:  W P James; A Astrup; N Finer; J Hilsted; P Kopelman; S Rössner; W H Saris; L F Van Gaal
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.

Authors:  D L Hansen; S Toubro; M J Stock; I A Macdonald; A Astrup
Journal:  Int J Obes Relat Metab Disord       Date:  1999-10

6.  Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine.

Authors:  M Apfelbaum; P Vague; O Ziegler; C Hanotin; F Thomas; E Leutenegger
Journal:  Am J Med       Date:  1999-02       Impact factor: 4.965

Review 7.  Metabolic benefits associated with sibutramine therapy.

Authors:  G J Krejs
Journal:  Int J Obes Relat Metab Disord       Date:  2002-12

8.  Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.

Authors:  B Barkeling; K Elfhag; P Rooth; S Rössner
Journal:  Int J Obes Relat Metab Disord       Date:  2003-06

9.  Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension.

Authors:  B P Grubb; D Samoil; D Kosinski; D Wolfe; M Lorton; E Madu
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

10.  The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects.

Authors:  J McGuirk; T Silverstone
Journal:  Int J Obes       Date:  1990-04
View more
  2 in total

Review 1.  Sibutramine on cardiovascular outcome.

Authors:  André J Scheen
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

2.  Slimmer or fertile? Pharmacological mechanisms involved in reduced sperm quality and fertility in rats exposed to the anorexigen sibutramine.

Authors:  Cibele S Borges; Gabriela Missassi; Enio S A Pacini; Luiz Ricardo A Kiguti; Marciana Sanabria; Raquel F Silva; Thais P Banzato; Juliana E Perobelli; André S Pupo; Wilma G Kempinas
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.